Identification of novel inhibitors of the PAX3-FOXO1 fusion oncogene in rhabdomyosarcoma

被引：0
|
作者：
Kim, Yong Yean [1 ]
Hawley, Robert [2 ]
Gryder, Berkley [1 ]
Pomella, Silvia [3 ]
Kowalczyk, Josh [1 ]
Sinniah, Ranu [1 ]
Song, Young [1 ]
Khan, Javed [1 ]
机构：
[1] NCI, Bethesda, MD 20892 USA
[2] George Washington Univ, Washington, DC USA
[3] Osped Pediat Bambino Gesu, Rome, Italy
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-4175
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4175
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Endogenous HiBiT-tagging of PAX3-FOXO1 reveals downregulation of the fusion oncogene by CDK inhibitors and has synergy with vincristine
    Kim, Yong Yean
    Jia, Katrina
    Churiwal, Mehal
    Hawley, Teresa
    Pomella, Silvia
    Evans, Christine
    Chari, Raj
    Milewski, David
    Sinniah, Ranuka
    Song, Young
    Chou, Hsien-Chao
    Wen, Xinyu
    Thomas, Craig
    Ceribelli, Michele
    Wei, Jun
    Hawley, Robert
    Khan, Javed
    CANCER RESEARCH, 2024, 84 (06)
  • [22] FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma
    David Milewski
    Samriddhi Shukla
    Berkley E. Gryder
    Arun Pradhan
    Johnny Donovan
    Parvathi Sudha
    Sushmitha Vallabh
    Athena Pyros
    Yan Xu
    Artem Barski
    Sara Szabo
    Brian Turpin
    Joseph G. Pressey
    Douglas P. Millay
    Javed Khan
    Vladimir V. Kalinichenko
    Tanya V. Kalin
    Oncogene, 2021, 40 : 2182 - 2199
  • [23] The hunt for a PAX3-FOXO1 motif
    Johanson, Kelly
    Collins, Chantelle
    Stewart, Desmond
    Cherlin, Tess
    FASEB JOURNAL, 2014, 28 (01):
  • [24] A single cysteine in PAX3-FOXO1 is relevant for transactivation and survival of rhabdomyosarcoma cells
    Schafer, Beat W.
    Benischke, Katharina
    Wurth, Jakob
    Laubscher, Dominik
    Ngo, Quy A.
    Danielli, Sara
    Wachtel, Marco
    CLINICAL CANCER RESEARCH, 2022, 28 (18)
  • [25] PAX3-FOXO1 dictates myogenic reprogramming and rhabdomyosarcoma identity in endothelial progenitors
    Searcy, Madeline B.
    Larsen, Randolph K.
    Stevens, Bradley T.
    Zhang, Yang
    Jin, Hongjian
    Drummond, Catherine J.
    Langdon, Casey G.
    Gadek, Katherine E.
    Vuong, Kyna
    Reed, Kristin B.
    Garcia, Matthew R.
    Xu, Beisi
    Kimbrough, Darden W.
    Adkins, Grace E.
    Djekidel, Nadhir
    Porter, Shaina N.
    Schreiner, Patrick A.
    Pruett-Miller, Shondra M.
    Abraham, Brian J.
    Rehg, Jerold E.
    Hatley, Mark E.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [26] UCHL5 and PAX3-FOXO1 resolve replication stress in rhabdomyosarcoma
    Sabnis, Amit J.
    Sahu, Pushpendra K.
    Pan, Yue
    CANCER RESEARCH, 2024, 84 (06)
  • [27] The KRAS/PAX3-FOXO1 networks control the cell proliferation in rhabdomyosarcoma cells
    Sugito, Nobuhiko
    Kuranaga, Yuki
    Shinohara, Haruka
    Tsujino, Takuya
    Tokumaru, Yoshihisa
    Heishima, Kazuki
    Akao, Yukihiro
    CANCER SCIENCE, 2018, 109 : 694 - 694
  • [28] PAX3-FOXO1 dictates myogenic reprogramming and rhabdomyosarcoma identity in endothelial progenitors
    Madeline B. Searcy
    Randolph K. Larsen
    Bradley T. Stevens
    Yang Zhang
    Hongjian Jin
    Catherine J. Drummond
    Casey G. Langdon
    Katherine E. Gadek
    Kyna Vuong
    Kristin B. Reed
    Matthew R. Garcia
    Beisi Xu
    Darden W. Kimbrough
    Grace E. Adkins
    Nadhir Djekidel
    Shaina N. Porter
    Patrick A. Schreiner
    Shondra M. Pruett-Miller
    Brian J. Abraham
    Jerold E. Rehg
    Mark E. Hatley
    Nature Communications, 14
  • [29] The effect of the PAX3-FOXO1 fusion gene on muscle cells.
    Roeb, WL
    Boyer, AD
    Cavenee, WK
    Arden, KC
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2004, 52 : S8 - S8
  • [30] PAX3-FOXO1 a target genes in alveolar rhabdomyosarcoma: Possible therapeutic targets
    Marshall, Amy D.
    van der Ent, Martijn A.
    Grosveld, Gerard C.
    CANCER RESEARCH, 2010, 70
12345